Forte Biosciences, Inc. (FBRX)
NASDAQ
Market Cap
$17.49M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
289 of 809
Rank in Industry
168 of 445
Largest Insider Buys in Sector
FBRX Stock Price History Chart
FBRX Stock Performance
About Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Insider Activity of Forte Biosciences, Inc.
Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $75,040 and sold $0 worth of Forte Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $138,422 and sold $4.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wagner Paul A. (See Remarks) — $75,040.
The last purchase of 10,000 shares for transaction amount of $7,525 was made by Wagner Paul A. (See Remarks) on 2023‑12‑18.
List of Insider Buy and Sell Transactions, Forte Biosciences, Inc.
| 2023-12-18 | Wagner Paul A. | See Remarks | 10,000 0.0286% | $0.75 | $7,525 | -3.45% | ||
| 2023-12-14 | Wagner Paul A. | See Remarks | 10,000 0.0287% | $0.72 | $7,200 | +1.38% | ||
| 2023-12-13 | Wagner Paul A. | See Remarks | 10,520 0.0284% | $0.70 | $7,351 | 0.00% | ||
| 2023-12-12 | Wagner Paul A. | See Remarks | 4,776 0.013% | $0.65 | $3,088 | +6.67% | ||
| 2023-12-11 | Wagner Paul A. | See Remarks | 25,000 0.0719% | $0.65 | $16,188 | +12.94% | ||
| 2023-12-08 | Wagner Paul A. | See Remarks | 15,000 0.0406% | $0.62 | $9,300 | +11.11% | ||
| 2023-12-07 | Wagner Paul A. | See Remarks | 36,203 0.0971% | $0.58 | $21,168 | +16.57% | ||
| 2023-11-22 | Wagner Paul A. | See Remarks | 400 0.0011% | $0.43 | $172 | +61.24% | ||
| 2023-11-20 | Wagner Paul A. | See Remarks | 6,966 0.0175% | $0.44 | $3,048 | +43.83% | ||
| 2022-12-16 | Wagner Paul A. | See Remarks | 44,024 0.2759% | $1.07 | $47,000 | +2.04% | ||
| 2022-12-15 | Wagner Paul A. | See Remarks | 55,976 0.3253% | $1.03 | $57,672 | -1.96% | ||
| 2021-09-07 | Sale | Wagner Paul A. | See Remarks | 1M 7.2851% | $4.35 | $4.35M | -65.57% | |
| 2021-09-07 | Sale | Riley Antony A | Chief Financial Officer | 25,000 0.1778% | $4.24 | $106,105 | -65.57% | |
| 2020-06-29 | Riley Antony A | Chief Financial Officer | 2,000 0.0544% | $14.11 | $28,220 | +145.46% | ||
| 2020-06-26 | Riley Antony A | Chief Financial Officer | 4,700 0.1262% | $14.52 | $68,225 | +135.52% | ||
| 2020-06-25 | Wagner Paul A. | See Remarks | 7,000 0.1998% | $14.48 | $101,356 | +150.76% | ||
| 2020-04-14 | Oliveira Steven Michael | 10 percent owner | 74,301 0.1242% | $1.19 | $88,418 | +54.56% | ||
| 2020-03-02 | Oliveira Steven Michael | 10 percent owner | 65,149 0.0283% | $1.35 | $87,756 | -0.52% | ||
| 2019-05-30 | Hasnain Faheem | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% | ||
| 2019-05-28 | FOLETTA MARK G | EVP & Chief Financial Officer | 5,000 0.0031% | $4.29 | $21,475 | -73.15% |
Insider Historical Profitability
34.48%
| Wagner Paul A. | See Remarks | 1823236 5.0178% | $0.48 | 12 | 1 | +50.28% |
| Oliveira Steven Michael | 10 percent owner | 2873450 7.9082% | $0.48 | 2 | 0 | +27.02% |
| Hasnain Faheem | director | 245857 0.6766% | $0.48 | 2 | 0 | <0.0001% |
| FOLETTA MARK G | EVP & Chief Financial Officer | 15042 0.0414% | $0.48 | 2 | 0 | <0.0001% |
| SCHIMMEL PAUL | director | 13623 0.0375% | $0.48 | 1 | 0 | <0.0001% |
| Duvall Martin J | Chief Executive Officer | 13605 0.0374% | $0.48 | 1 | 0 | |
| Riley Antony A | Chief Financial Officer | 11065 0.0305% | $0.48 | 2 | 1 | +140.49% |
| GRUBER HARRY E | President, Science&Innovation | 9744 0.0268% | $0.48 | 2 | 0 | <0.0001% |
| Das Asha | SVP & Chief Medical Officer | 2500 0.0069% | $0.48 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Tybourne Capital Management HK Ltd | $2.52M | 9.95 | 3.62M | 0% | +$0 | 0.43 | |
| Perceptive Advisors | $2.27M | 8.96 | 3.27M | 0% | +$0 | <0.01 | |
| Bvf Inc Il | $2.09M | 8.18 | 2.98M | 0% | +$0 | 0.02 | |
| Alger | $1.28M | 5.05 | 1.84M | 0% | +$0 | 0.01 | |
| Farallon Capital | $1.27M | 4.97 | 1.81M | 0% | +$0 | 0.01 | |
| Bml Capital Management Llc | $1.23M | 4.83 | 1.76M | 0% | +$0 | 0.93 | |
| The Vanguard Group | $463,133.00 | 1.83 | 665,230 | 0% | +$0 | <0.0001 | |
| Geode Capital Management | $240,705.00 | 0.94 | 343,432 | +2.03% | +$4,784.91 | <0.0001 | |
| BlackRock | $121,736.00 | 0.48 | 174,858 | -4.09% | -$5,197.82 | <0.0001 | |
| Renaissance Technologies | $92,000.00 | 0.36 | 132,100 | +1.77% | +$1,601.82 | <0.0001 | |
| State Street | $29,194.00 | 0.11 | 41,664 | 0% | +$0 | <0.0001 | |
| Two Sigma | $28,450.00 | 0.11 | 40,864 | -0.24% | -$69.62 | <0.0001 | |
| Citadel Advisors LLC | $19,774.00 | 0.08 | 28,220 | +227.49% | +$13,735.99 | <0.0001 | |
| Northern Trust | $18,735.00 | 0.07 | 26,911 | 0% | +$0 | <0.0001 | |
| Two Sigma Advisers LP | $17,259.00 | 0.07 | 24,791 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $14,463.00 | 0.06 | 20,774 | +0.16% | +$23.67 | <0.0001 | |
| Group One Trading | $10,179.00 | 0.04 | 14,527 | -8.21% | -$910.90 | <0.0001 | |
| Aries Wealth Management | $9,051.00 | 0.04 | 13,000 | 0% | +$0 | <0.01 | |
| Tower Research Capital | $8,103.00 | 0.03 | 11,642 | +101.38% | +$4,079.34 | <0.0001 | |
| TWO SIGMA SECURITIES LLC | $7,743.00 | 0.03 | 11,122 | -27.93% | -$3,000.57 | <0.0001 | |
| HSBC | $7,529.00 | 0.03 | 10,745 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $754.00 | <0.01 | 1,080 | 0% | +$0 | <0.0001 | |
| Morgan Stanley | $692.00 | <0.01 | 994 | 0% | +$0 | <0.0001 | |
| Loring Wolcott Coolidge Fiduciary Advisors Llp Ma | $139.00 | <0.01 | 193 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $176.00 | <0.01 | 253 | +2.02% | +$3.48 | <0.0001 | |
| Russell Investments Group Ltd | $317.00 | <0.01 | 453 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 137 | New | +$0 | <0.0001 | |
| Qube Research & Technologies | $2.00 | <0.01 | 3 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $12.00 | <0.01 | 17 | 0% | +$0 | <0.0001 | |
| UBS | $23.00 | <0.01 | 33 | -77.4% | -$78.76 | <0.0001 |